Trials / Conditions / Stage III Ureter Cancer AJCC v7
Stage III Ureter Cancer AJCC v7
3 registered clinical trials studyying Stage III Ureter Cancer AJCC v7.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advance NCT03244384 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot NCT02812420 | M.D. Anderson Cancer Center | EARLY_Phase 1 |
| Completed | Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or C NCT02178241 | National Cancer Institute (NCI) | Phase 2 |